3Arpir D.perol D,Blag Ty.Variations of circulation interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneuronitis[J].J Clin Onol,2005;23(34):8748-56.
2Kong FM, Ten Haken RK, Schipper M J, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small cell lung cancer: long-term results of a radiation dose escalation study[J], Int J Radiat Oncol Biol Phys, 2005, 63(2): 324-333.
3Rodrigues G, Lock MD, Souza D, et al, Prediction of radiation pneumonitis by dose-volume histograme parameters in lung cancer-a systematic review [J]. Radiother Oncol, 2004, 71(2):127-138,
4Wang S,Liao Z,Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)[J]. Int J Radiat Oneol Biol Phys, 2006, 66(5): 1399-1407.
5Allen AM,Czerminska M,Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma[J]. Int J Radiat Oncol Biol Phys, 2006, 65(3):640-645.
6Kong FM,Hayman JA, Griffith KA, et al. Final toxicity resuits of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC):predictors for radiation pneumonitis and fibrosis [J]. Int J Radiat Oncol Biol Phys, 2006, 65(4): 1075-1086.
7Clenton SJ, Fisher PM, Conway J, et al. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma [J]. Clin Oncol (R Coll Radiol), 2005, 17(8):599-603.
8Hope A J, Lindsay PE, El Naqa I, et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters[J]. Int J Radiat Oncol Biol Phys, 2006, 65(1): 112-124.
9Rancati T, Ceresoli GL, Gagliardi G, et al. Factors predicting radiation pneumonitis in lung cancer patients: retrospective study[J]. Radiother Oncol, 2003, 67(3):275-283.
10Piotrowski T, Matecka-Nowak M, Milecki P, et al. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy[J]. Neoplasma, 2005, 52(1):56-62.
3Lawrence B,Soren M,Joseph O,et al.Radiation dose-volume effects in the lung[J].Int.J.Radiation Oncology Biol.Phys,2010,76(3):70-76.
4Marks L B,Bentzen S M,Deasy J O,et al.radiation dosevolume effects in the lung[J].Int J Radiation Oncology Biol Phys,2010,76(3),70-76.
5De Jaeger K,Seppenwoolde Y,Kampinga H H,et al.Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small cell lung cancer[J].Int J Radial Oncol Biol Phys,2004,58(5):1378-1387.
6Tsujino K,Hirota S,Endo M,et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer[J].Int J Radiat Oncol Biol Phys,2003,55(1):110-115.
7Yorke E D,Jackson A,Rosenzweig K E,et al.Correlation of dosimetric factors and radiation pneumonitis for non-small cell lung cancer patients in recently completed dose escalation study[J].Radiat Oncol Biol Phys,2005,63 (3):672-682.
8Kwa S L,Lebesque J V,Theuws J C.Radiation pneumonitis as a function of mean lung dose:An analysis of pooled data of 540 patients[J].Int J Radiat Oncol Biol Phys,1998,42(1):1-9.
9Vivek M T.Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer:Pulmonary function,prediction,and prevention International Journal of Radiation Oncology[J].Biology Physics,2005,63(1):5-24.
10Tsujino K,Hirota S,Endo M,et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer[J].Int J Radial Oncol Biol Phys,2003,55 (1):110-115.
